Cargando…
Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka
BACKGROUND: Pesticide ingestion is a common method of self-harm in the rural developing world. In an attempt to reduce the high case fatality seen with the herbicide paraquat, a novel formulation (INTEON) has been developed containing an increased emetic concentration, a purgative, and an alginate t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253611/ https://www.ncbi.nlm.nih.gov/pubmed/18303942 http://dx.doi.org/10.1371/journal.pmed.0050049 |
_version_ | 1782151122089148416 |
---|---|
author | Wilks, Martin F Fernando, Ravindra Ariyananda, P. L Eddleston, Michael Berry, David J Tomenson, John A Buckley, Nicholas A Jayamanne, Shaluka Gunnell, David Dawson, Andrew |
author_facet | Wilks, Martin F Fernando, Ravindra Ariyananda, P. L Eddleston, Michael Berry, David J Tomenson, John A Buckley, Nicholas A Jayamanne, Shaluka Gunnell, David Dawson, Andrew |
author_sort | Wilks, Martin F |
collection | PubMed |
description | BACKGROUND: Pesticide ingestion is a common method of self-harm in the rural developing world. In an attempt to reduce the high case fatality seen with the herbicide paraquat, a novel formulation (INTEON) has been developed containing an increased emetic concentration, a purgative, and an alginate that forms a gel under the acid conditions of the stomach, potentially slowing the absorption of paraquat and giving the emetic more time to be effective. We compared the outcome of paraquat self-poisoning with the standard formulation against the new INTEON formulation following its introduction into Sri Lanka. METHODS AND FINDINGS: Clinical data were prospectively collected on 586 patients with paraquat ingestion presenting to nine large hospitals across Sri Lanka with survival to 3 mo as the primary outcome. The identity of the formulation ingested after October 2004 was confirmed by assay of blood or urine samples for a marker compound present in INTEON. The proportion of known survivors increased from 76/297 with the standard formulation to 103/289 with INTEON ingestion, and estimated 3-mo survival improved from 27.1% to 36.7% (difference 9.5%; 95% confidence interval [CI] 2.0%–17.1%; p = 0.002, log rank test). Cox proportional hazards regression analyses showed an approximately 2-fold reduction in toxicity for INTEON compared to standard formulation. A higher proportion of patients ingesting INTEON vomited within 15 min (38% with the original formulation to 55% with INTEON, p < 0.001). Median survival time increased from 2.3 d (95% CI 1.2–3.4 d) with the standard formulation to 6.9 d (95% CI 3.3–10.7 d) with INTEON ingestion (p = 0.002, log rank test); however, in patients who did not survive there was a comparatively smaller increase in median time to death from 0.9 d (interquartile range [IQR] 0.5–3.4) to 1.5 d (IQR 0.5–5.5); p = 0.02. CONCLUSIONS: The survey has shown that INTEON technology significantly reduces the mortality of patients following paraquat ingestion and increases survival time, most likely by reducing absorption. |
format | Text |
id | pubmed-2253611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-22536112008-02-23 Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka Wilks, Martin F Fernando, Ravindra Ariyananda, P. L Eddleston, Michael Berry, David J Tomenson, John A Buckley, Nicholas A Jayamanne, Shaluka Gunnell, David Dawson, Andrew PLoS Med Research Article BACKGROUND: Pesticide ingestion is a common method of self-harm in the rural developing world. In an attempt to reduce the high case fatality seen with the herbicide paraquat, a novel formulation (INTEON) has been developed containing an increased emetic concentration, a purgative, and an alginate that forms a gel under the acid conditions of the stomach, potentially slowing the absorption of paraquat and giving the emetic more time to be effective. We compared the outcome of paraquat self-poisoning with the standard formulation against the new INTEON formulation following its introduction into Sri Lanka. METHODS AND FINDINGS: Clinical data were prospectively collected on 586 patients with paraquat ingestion presenting to nine large hospitals across Sri Lanka with survival to 3 mo as the primary outcome. The identity of the formulation ingested after October 2004 was confirmed by assay of blood or urine samples for a marker compound present in INTEON. The proportion of known survivors increased from 76/297 with the standard formulation to 103/289 with INTEON ingestion, and estimated 3-mo survival improved from 27.1% to 36.7% (difference 9.5%; 95% confidence interval [CI] 2.0%–17.1%; p = 0.002, log rank test). Cox proportional hazards regression analyses showed an approximately 2-fold reduction in toxicity for INTEON compared to standard formulation. A higher proportion of patients ingesting INTEON vomited within 15 min (38% with the original formulation to 55% with INTEON, p < 0.001). Median survival time increased from 2.3 d (95% CI 1.2–3.4 d) with the standard formulation to 6.9 d (95% CI 3.3–10.7 d) with INTEON ingestion (p = 0.002, log rank test); however, in patients who did not survive there was a comparatively smaller increase in median time to death from 0.9 d (interquartile range [IQR] 0.5–3.4) to 1.5 d (IQR 0.5–5.5); p = 0.02. CONCLUSIONS: The survey has shown that INTEON technology significantly reduces the mortality of patients following paraquat ingestion and increases survival time, most likely by reducing absorption. Public Library of Science 2008-02 2008-02-26 /pmc/articles/PMC2253611/ /pubmed/18303942 http://dx.doi.org/10.1371/journal.pmed.0050049 Text en : © 2008 Wilks et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Wilks, Martin F Fernando, Ravindra Ariyananda, P. L Eddleston, Michael Berry, David J Tomenson, John A Buckley, Nicholas A Jayamanne, Shaluka Gunnell, David Dawson, Andrew Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka |
title | Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka |
title_full | Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka |
title_fullStr | Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka |
title_full_unstemmed | Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka |
title_short | Improvement in Survival after Paraquat Ingestion Following Introduction of a New Formulation in Sri Lanka |
title_sort | improvement in survival after paraquat ingestion following introduction of a new formulation in sri lanka |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253611/ https://www.ncbi.nlm.nih.gov/pubmed/18303942 http://dx.doi.org/10.1371/journal.pmed.0050049 |
work_keys_str_mv | AT wilksmartinf improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT fernandoravindra improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT ariyanandapl improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT eddlestonmichael improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT berrydavidj improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT tomensonjohna improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT buckleynicholasa improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT jayamanneshaluka improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT gunnelldavid improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka AT dawsonandrew improvementinsurvivalafterparaquatingestionfollowingintroductionofanewformulationinsrilanka |